Skip to main content
OpenTrials
Completed

NCT Number: NCT03940261

Physiological Benefits of High-intensity Interval Training for Individuals With Parkinson's Disease

Aerobic exercise is recommended for individuals with Parkinson's disease (PD) and can improve quality of life, both physically and mentally. The most efficacious program to achieve these exercise benefits is unknown. Recently, high-intensity interval training (HIIT) has been shown to be safe and more effective in many high-risk populations with limited exercise tolerance. Shorter bouts of exercise are likely better tolerated in PD due to difficulty sustaining muscle contractions. The goal of this project is to determine whether HIIT produces superior cardiorespiratory, neuromuscular, biomechanical, and clinical adaptations than conventional continuous moderate intensity training (CMIT) in PD.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Parkinson Disease Basal Ganglia Diseases Brain Diseases Central Nervous System Diseases Exercise Training Movement Disorders Nervous System Diseases Neurodegenerative Diseases Parkinsonian Disorders Synucleinopathies

Age range

45 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Guelph

Guelph, Ontario, N1G 2W1, Canada

About this study

The specific research aims are to compare, in PD, the effects of HIIT or CMIT on: 1) maximal exercise capacity; 2) neural and non-neural factors contributing to muscle strength, power and fatigability; 3) biomechanical measures of postural stability and gait; and 4) Clinical markers (Mini-BESTest and Unified Parkinson's Disease Rating Scale (UPDRS)). The investigators hypothesize that, HIIT will produce greater improvements in: 1) exercise capacity; 2) muscle strength, power and reduced fatigability; 3) stability and gait velocity; and 4) clinical markers.

Methods: This pilot project will involve a randomized trial of 30 individuals with PD comparing the effects of HIIT and CMIT. Training will be completed thrice weekly for 10 weeks. Participants will include men and women between 50-85 years of age, who are able to stand unsupported for 1 min, walk 18m without use of an aid, and mount a stationary bike. Participants will be randomized to either HIIT (10, 1-minute cycling intervals at 90% of peak power output, each separated by 1-min at 10% peak power output) or CMIT (30-50min cycling at 60% of peak power output). Participants will undergo the following pre- and post-training assessments: Cardiovascular testing will examine hemodynamic and efferent muscle sympathetic responses to static handgrip exercise and post-exercise circulatory occlusion; Neuromuscular testing will examine muscle activity (electromyography) during voluntary and electrically stimulated contractions of the knee extensors; Biomechanical testing will examine whole-body stability, gait, and balance patterns; and Clinical risk assessments (Mini-BESTest and UPDRS).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men and women between 45-85 years of age
  • Clinical diagnosis of Parkinson disease
  • Able to stand unsupported for 1 minute
  • Able to walk 18 metres without aid
  • Able to mount a stationary bike

Exclusion criteria

  • History of dementia
  • History of stroke
  • Type 1 diabetes
  • Autonomic neuropathy
  • Currently involved in formal exercise training (>3 day per week).

Treatment and study plan

High Intensity Interval Training

Other

Participants will complete exercise training 3x/week for 10 weeks. Exercise will consist of 10, 1-minute cycling intervals at 90% of peak power output, each separated by 1-min at 10% peak power output.

Continuous Moderate Intensity Training

Other

Participants will complete exercise training 3x/week for 10 weeks. Exercise will consist of 30-50 minutes of cycling at 60% peak power output.

Primary outcomes

  1. Maximal exercise capacity

    Time frame: Change from baseline following 10 weeks of aerobic exercise training

    VO2 max

Secondary outcomes

  1. Handgrip strength

    Time frame: Change from baseline following 10 weeks of aerobic exercise training

    Maximal handgrip strength

  2. Blood Pressure

    Time frame: Change from baseline following 10 weeks of aerobic exercise training

    Systolic and Diastolic Blood Pressure

  3. Heart Rate

    Time frame: Change from baseline following 10 weeks of aerobic exercise training

    Cardiovascular measure

  4. Mini-Balance Evaluation Systems Test (Mini-BESTest)

    Time frame: Change from baseline following 10 weeks of aerobic exercise training

    Rating scale consisting of 14 items that are each scored from 0-2, where "0" indicates the lowest level of function and "2" the highest level of function. The test has a maximum score of 28 points.

  5. Unified Parkinson's Disease Rating Scale (UPDRS)

    Time frame: Change from baseline following 10 weeks of aerobic exercise training

    We will use the rating scale to examine 3 segments. 1) MENTATION, BEHAVIOR AND MOOD - 4 questions scored between "0" and "4"; 2) ACTIVITIES OF DAILY LIVING - 13 questions scored between "0" and "4"; and 3) MOTOR EXAMINATION - 14 questions scored between "0" and "4". In each case, a score of "0" indicates normal responses.

Sponsors and collaborators

Lead sponsor

University of Guelph

Other

Collaborators

  • Parkinson Society Canada
  • YMCA

Registry information

Important dates

Study start
2019
Primary completion
2022
Study completion
2022
First posted
May 7, 2019
Registry last updated
Jul 28, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.